Immuneering Corp — Investor Relations & Filings
Filings indexed
300
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
IMRX
Immuneering Corp. is a clinical-stage oncology company focused on developing medicines for broad populations of cancer patients. The company utilizes its proprietary computational Disease Cancelling Technology to design and develop novel therapeutics. Its lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily deep cyclic inhibitor of the MEK pathway. Atebimetinib is being evaluated in Phase 2a clinical trials for patients with advanced solid tumors, including pancreatic cancer. The drug is designed to maximize therapeutic activity while providing an improved tolerability profile, with the goal of helping patients outlive their disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-15 | English | |
| 8-K | 2026-05-15 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46353441 | 10-Q | 2026-05-15 | English | ||
| 46353436 | 8-K | 2026-05-15 | English | ||
| 31731541 | 4 Filing | 2026-02-05 | English | ||
| 31731482 | 4 Filing | 2026-02-05 | English | ||
| 31731473 | 4 Filing | 2026-02-05 | English | ||
| 31731465 | 4 Filing | 2026-02-05 | English | ||
| 31731434 | 4 Filing | 2026-02-05 | English | ||
| 31731427 | 4 Filing | 2026-02-05 | English | ||
| 31731413 | 4 Filing | 2026-02-05 | English | ||
| 31731511 | SCHEDULE 13G/A Filing | 2026-01-22 | English | ||
| 13211491 | FORM 4 | 2026-01-21 | English | ||
| 13211492 | FORM 4 | 2026-01-20 | English | ||
| 13211493 | FORM 4 | 2026-01-16 | English | ||
| 13211494 | Major Shareholding Notification 2026 | 2026-01-15 | English | ||
| 13211495 | FORM 4 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biovica International B
Develops blood-based biomarker assays for cancer therapy mo…
|
BIOVIC | SE | Professional, scientific and te… |
|
Boji Medical Technology Co., Ltd.
A CRO providing full-service pharmaceutical and medical dev…
|
300404 | CN | Professional, scientific and te… |
|
Bonus BioGroup Ltd.
A clinical-stage biotech firm developing cell therapy and t…
|
BONS | IL | Professional, scientific and te… |
|
BPH GLOBAL LTD
Biotech firm focused on plant-based health products and fun…
|
BP8 | AU | Professional, scientific and te… |
|
BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical,…
|
BNN | DE | Professional, scientific and te… |
|
BriaCell Therapeutics Corp.
Clinical-stage immuno-oncology company developing cellular …
|
BCTX | CA | Professional, scientific and te… |
|
Bright Minds Biosciences Inc.
Developing innovative serotonin-based drugs for neurologica…
|
DRUG | CA | Professional, scientific and te… |
|
BRIM
Develops therapies for ophthalmology and degenerative disea…
|
6885 | TW | Professional, scientific and te… |
|
BSF ENTERPRISE PLC
Develops cell-based solutions for cultivated meat, leather,…
|
BSFA | GB | Professional, scientific and te… |
|
BullFrog AI Holdings, Inc.
A technology company applying AI and machine learning to dr…
|
BFRG | US | Professional, scientific and te… |
Immuneering Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32973/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32973 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32973 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32973 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32973}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immuneering Corp (id: 32973)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.